Researchers compared the main adverse events of treatments for advanced basal cell carcinoma, finding sonidegib is tolerated better by more patients because of the lower overall incidence rate and a slower, less severe onset of certain AEs.
Researchers compared the main adverse events of treatments for advanced basal cell carcinoma, finding sonidegib is tolerated better by more patients because of the lower overall incidence rate and a slower, less severe onset of certain AEs.
Researchers compared the main...